lis vs lims, read as lims vs lis or as lis lims from the other direction, and where sdms lims sits beside them: why laboratory information management systems lims, a lims laboratory information management system and a lims laboratory management system differ from a clinical laboratory information system, and how a lims system laboratory chooses

These acronyms are used interchangeably in procurement documents and they describe genuinely different systems built around different central objects. A clinical laboratory information system is organised around a patient and an order; a laboratory information management system is organised around a sample and a test; a scientific data management system is organised around the raw instrument file. Buying the wrong one is an expensive mistake that takes a year to become obvious.

the programme a clinical laboratory information system operates under
CLIA
the electronic records rule every one of these systems has to meet
Part 11
the interface standard a LIS speaks to the health record
HL7

Figures in this panel are the regulatory programme and the interface standards these systems operate under, named from the regulations themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a software price index it has not measured.

What each system is actually built around

  1. A LIS is built around the patient and the order. It receives orders from a clinical system, holds patient demographics, produces a patient-oriented report and interfaces to the electronic health record, conventionally over HL7. Its world is people and episodes of care, and its regulatory context is clinical.
  2. A LIMS is built around the sample and the test. It accessions a sample, routes it through methods and batches, holds the quality control around those batches, and reports against a specification. Its world is specimens and analyses, and it serves research, testing and manufacturing laboratories rather than clinical care.
  3. An SDMS is built around the raw file. It captures the instrument's raw output, indexes it, keeps it in a controlled repository and makes it retrievable years later regardless of which software version produced it. It is the answer to the question of where the actual chromatogram lives when the chromatography data system is retired.
  4. An ELN is built around the experiment. It records what a person did and why, in narrative form, with attachments. It overlaps with a LIMS at the edges and is the wrong place to hold a structured result set, which is the commonest reason a laboratory ends up with both.
  5. Decide from the central object, not the feature list. Ask what the thing your laboratory tracks actually is. If the answer is a patient, you want a LIS. If it is a sample, a LIMS. If it is a file, an SDMS. A vendor can usually configure any of them to do a little of the others, and that configuration is where projects run over.

Where the two overlap and why that causes trouble

Both accession samples, both run quality control, both report. The difference is what a result is attached to and what the report is for, and a clinical report carries obligations about identity, turnaround and result release that a specification report does not.

A laboratory doing both clinical and research work usually needs both systems and an agreed boundary between them. Attempting one system across the boundary produces a configuration nobody can validate and a report nobody is confident issuing.

Interfaces are the real integration cost

A LIS lives or dies by its interface to the electronic health record, and that interface is a project with its own testing, not a checkbox. A LIMS lives by its instrument interfaces, which are a different discipline entirely.

Count the interfaces you actually need, name the systems on both ends, and get a per-interface price. Integration is where these projects overrun and it is almost always underestimated at selection.

Choosing when the laboratory is changing

A research laboratory moving towards regulated or clinical work should ask what the migration path looks like before buying, because retrofitting clinical identity handling and result release into a research system is not a configuration exercise.

Conversely a clinical laboratory adding research work should not force those samples through the patient model. The dummy patient record is a well known workaround and it corrupts the data for both purposes.

Common questions

What is the difference between LIS and LIMS?
A laboratory information system is patient-centred and built for clinical diagnostics, interfacing with the electronic health record. A laboratory information management system is sample-centred and built for testing, research and manufacturing laboratories reporting against specifications.
Can one system do both?
Some vendors offer both, and in practice the clinical and the non-clinical workflows are usually served by separate configurations even within one product. A laboratory doing both kinds of work should expect two configurations rather than one compromise.
Do I need an SDMS as well?
If raw instrument data has to be retrievable for years independently of the acquisition software, yes. Many laboratories discover this at the point a chromatography system is replaced and the old raw files become unopenable.
Where does an ELN fit?
Alongside, recording what was done and why. Keeping structured results in an ELN and narrative in a LIMS is the arrangement that causes the most trouble, and it is surprisingly common.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/lis-vs-lims/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices